| 000 | 01680cam a2200337 i 4500 | ||
|---|---|---|---|
| 999 |
_c33572 _d33572 |
||
| 001 | on1019845642 | ||
| 003 | OCoLC | ||
| 005 | 20220906083351.0 | ||
| 007 | ta | ||
| 008 | 181017s2019 paua bf 001 0 eng c | ||
| 020 | _a9780803669451 | ||
| 020 | _a0803669453 | ||
| 035 |
_a(OCoLC)1019845642 _z(OCoLC)987805037 _z(OCoLC)1019842600 _z(OCoLC)1042213399 |
||
| 040 | _aTH-BaNU | ||
| 060 |
_aQV735 _b.D445 2019 |
||
| 100 | 1 |
_aVallerand, April Hazard. _9107407 |
|
| 245 | 1 | 0 |
_aDavis's drug guide for nurses / _cApril Hazard Vallerand, Cynthia A. Sanoski. |
| 246 | 1 | _aDrug guide for nurses | |
| 250 | _a16th ed. | ||
| 260 |
_aPhiladelphia, PA : _bF.A. Davis Company, _cc2019. |
||
| 300 | _ax, 1478 p. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aHow to use Davis's drug guide for nurses -- Evidence-based practice and pharmacotherapeutics : implications for nurses -- Pharmacogenomics -- Medication errors : improving practices and patient safety -- Detecting and managing adverse drug reactions -- Overview of risk evaluation and mitigation systems (REMS) -- Special dosing considerations -- The cytochrome p450 system -- Educating patients about safe medication use -- Classifications -- Drug monographs in alphabetical order by generic name -- Drugs approved in Canada -- Natural/herbal products -- Medication safety tools. | |
| 650 | 4 |
_aPharmaceutical preparations _xAdministration & dosage. _9419846 |
|
| 650 | 4 |
_aDrug therapy _xNursing. _9426455 |
|
| 650 | 4 |
_aPharmacology, Clinical _xMethods. _9603414 |
|
| 700 | 1 |
_aSanoski, Cynthia A. _9791172 |
|
| 850 | _aKCNL | ||
| 942 |
_2nlm _cGB _01 |
||
| 948 | _hHELD BY TULIB - 94 OTHER HOLDINGS | ||